Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,5,1.1 [1.06-1.14],5.03198572321605e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP1,Insulin-like growth factor-binding protein 1,Inverse variance weighted,5,0.92 [0.89-0.96],6.85684433011853e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSO,Cathepsin O,Inverse variance weighted,5,1.07 [1.03-1.12],0.000236001660565974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,5,0.94 [0.9-0.97],0.000314268348106972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NFASC,Neurofascin,Inverse variance weighted,5,1.09 [1.04-1.14],0.000605580572914561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,5,0.94 [0.91-0.97],0.000779925279861057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSZ,Cathepsin Z,Inverse variance weighted,5,1.06 [1.02-1.1],0.00170807927906039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPP1,Osteopontin,Inverse variance weighted,5,0.93 [0.89-0.98],0.00289023689979203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,5,0.94 [0.91-0.98],0.00307620270654416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,5,1.06 [1.02-1.09],0.00328771779405761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHRDL1,Chordin-like protein 1,Inverse variance weighted,5,0.95 [0.92-0.98],0.004047220305974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,5,0.95 [0.91-0.98],0.00455406124393201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSG2,Desmoglein-2,Inverse variance weighted,5,0.92 [0.87-0.98],0.00646861036549716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSB,Cathepsin B,Inverse variance weighted,5,0.93 [0.88-0.98],0.00649028630406165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,5,0.96 [0.93-0.99],0.0075525044096705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,5,0.95 [0.91-0.99],0.0101692265680727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,5,0.95 [0.92-0.99],0.0110643736950391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITGB6,Integrin beta-6,Inverse variance weighted,5,1.05 [1.01-1.09],0.0118279504658226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REN,Renin,Inverse variance weighted,5,1.05 [1.01-1.09],0.0118302951038929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,5,0.96 [0.92-0.99],0.0120107446325345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.05 [1.01-1.09],0.0128008693077551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PLXNB2,Plexin-B2,Inverse variance weighted,5,1.06 [1.01-1.12],0.0133842154405311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,5,1.05 [1.01-1.09],0.0141490030565156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,5,0.95 [0.92-0.99],0.0153139153386083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,5,0.95 [0.91-0.99],0.0153327998484695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RSPO1,R-spondin-1,Inverse variance weighted,5,0.95 [0.91-0.99],0.0156348575370616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,5,0.93 [0.88-0.99],0.0161143154762091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AOC3,Membrane primary amine oxidase,Inverse variance weighted,5,1.04 [1.01-1.08],0.0173871580280936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CFD,Complement factor D,Inverse variance weighted,5,0.95 [0.92-0.99],0.0177269050040257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,5,0.95 [0.92-0.99],0.0184629789989484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,5,0.96 [0.92-0.99],0.0192916886112942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,5,0.96 [0.92-0.99],0.0202668895818803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,5,1.04 [1.01-1.08],0.0224756333410621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CKB,Creatine kinase B-type,Inverse variance weighted,5,0.9 [0.82-0.99],0.0235421324252878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,5,1.04 [1.01-1.08],0.0243060966609569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,APOA2,Apolipoprotein A-II,Inverse variance weighted,5,0.93 [0.87-0.99],0.024596849483088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300E,CMRF35-like molecule 2,Inverse variance weighted,5,0.95 [0.9-0.99],0.028261903616058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NRP1,Neuropilin-1,Inverse variance weighted,5,0.96 [0.92-1],0.0293865431684818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,0.96 [0.92-1],0.029521241651206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL14,C-C motif chemokine 14,Inverse variance weighted,5,0.96 [0.93-1],0.029741414698108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,5,0.96 [0.92-1],0.0297505486584654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD55,Complement decay-accelerating factor,Inverse variance weighted,5,0.96 [0.92-1],0.0311401396185264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLMP,CXADR-like membrane protein,Inverse variance weighted,5,0.93 [0.88-0.99],0.0312056611741609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,0.96 [0.92-1],0.031671099994935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,5,1.04 [1-1.08],0.0322344666637078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,5,0.96 [0.93-1],0.0330316248375584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,5,0.96 [0.92-1],0.0331808721114487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,5,0.96 [0.93-1],0.0332981543810892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSC2,Desmocollin-2,Inverse variance weighted,5,0.96 [0.92-1],0.0333080970428222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANXA5,Annexin A5,Inverse variance weighted,5,0.96 [0.92-1],0.0348951098116057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FSTL3,Follistatin-related protein 3,Inverse variance weighted,5,0.95 [0.91-1],0.0357790187382476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FBLN2,Fibulin-2,Inverse variance weighted,5,0.96 [0.93-1],0.0358566384363242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK4,Kallikrein-4,Inverse variance weighted,5,0.97 [0.94-1],0.036838521484019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HEPH,Hephaestin,Inverse variance weighted,5,1.05 [1-1.09],0.0392391686014635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,5,0.96 [0.93-1],0.0395240837405566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OGN,Mimecan,Inverse variance weighted,5,0.96 [0.92-1],0.039544484572068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DPT,Dermatopontin,Inverse variance weighted,5,0.96 [0.92-1],0.0395991915426556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,5,0.91 [0.83-1],0.0405119008689001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,5,0.96 [0.93-1],0.0406907697792072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COLEC12,Collectin-12,Inverse variance weighted,5,0.95 [0.9-1],0.0412430324186594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PKD1,Polycystin-1,Inverse variance weighted,5,1.04 [1-1.08],0.0418902508045876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRG2,Bone marrow proteoglycan,Inverse variance weighted,5,0.96 [0.93-1],0.0423882309805837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA12,Carbonic anhydrase 12,Inverse variance weighted,5,0.96 [0.92-1],0.0423945258845308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PI16,Peptidase inhibitor 16,Inverse variance weighted,5,0.96 [0.93-1],0.0430362728113503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,5,0.96 [0.93-1],0.0439328193519393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,5,0.97 [0.93-1],0.0457004535297661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.04 [1-1.08],0.0501098755666131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,5,0.97 [0.93-1],0.0501854647274735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,5,0.96 [0.92-1],0.0508762584830976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,5,0.95 [0.91-1],0.0551326062287091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LCN15,Lipocalin-15,Inverse variance weighted,5,1.04 [1-1.07],0.0578324311323824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,5,1.04 [1-1.08],0.057989771875487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,5,0.96 [0.93-1],0.0606350732147624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGRP,Agouti-related protein,Inverse variance weighted,5,1.05 [1-1.11],0.0608530390537012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,5,0.96 [0.92-1],0.0613588558408023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VWC2,Brorin,Inverse variance weighted,5,0.97 [0.93-1],0.061463723965109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,5,0.96 [0.91-1],0.0658034652337526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GCG,Pro-glucagon,Inverse variance weighted,5,1.07 [0.99-1.16],0.0670463845849225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,5,0.94 [0.89-1],0.0708453816295237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCG2,Secretogranin-2,Inverse variance weighted,5,1.05 [1-1.1],0.0723412853215591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,5,0.93 [0.86-1.01],0.0762419030564106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,5,0.97 [0.93-1],0.0785673123874483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,5,0.97 [0.93-1],0.0796927894433323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CYTL1,Cytokine-like protein 1,Inverse variance weighted,5,0.96 [0.92-1],0.080413573959978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GM2A,Ganglioside GM2 activator,Inverse variance weighted,5,0.97 [0.94-1],0.0824415174785013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,5,0.97 [0.93-1],0.0827870592286221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,5,0.97 [0.93-1],0.0830740692381534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FOLR2,Folate receptor beta,Inverse variance weighted,5,0.96 [0.92-1.01],0.0842136813818323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,5,1.05 [0.99-1.1],0.0852745670224739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,5,0.96 [0.92-1.01],0.0861565142918117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,5,1.04 [1-1.08],0.0865291012688283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.96 [0.92-1.01],0.086699431649987,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GDF15,Growth/differentiation factor 15,Inverse variance weighted,5,1.03 [1-1.08],0.0871404240929641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,5,0.97 [0.93-1.01],0.0901767561130776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,5,1.04 [0.99-1.08],0.0904550377388905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,5,0.98 [0.95-1],0.0920282644089472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300C,CMRF35-like molecule 6,Inverse variance weighted,5,0.97 [0.94-1.01],0.0921940345959245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.96 [0.92-1.01],0.094440061812143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,5,1.07 [0.99-1.15],0.0947922562297925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPY,Pro-neuropeptide Y,Inverse variance weighted,5,1.07 [0.99-1.16],0.0952054899240833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,5,0.97 [0.93-1.01],0.0972831027249919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,5,0.97 [0.94-1.01],0.0978510611004411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD99,CD99 antigen,Inverse variance weighted,5,0.96 [0.92-1.01],0.0987135082513411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,5,1.05 [0.99-1.12],0.0994078698910043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,5,0.96 [0.92-1.01],0.100059626463772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP12,Macrophage metalloelastase,Inverse variance weighted,5,1.03 [0.99-1.07],0.10022390220655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,5,0.96 [0.91-1.01],0.103764151070909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NEFL,Neurofilament light polypeptide,Inverse variance weighted,5,1.03 [0.99-1.06],0.112030771265261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,5,1.03 [0.99-1.07],0.113907205065967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,5,0.97 [0.93-1.01],0.11760704158738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,STC1,Stanniocalcin-1,Inverse variance weighted,5,1.04 [0.99-1.09],0.119364725934196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,5,0.97 [0.93-1.01],0.120047167878879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PALM,Paralemmin-1,Inverse variance weighted,5,0.97 [0.92-1.01],0.121082836657349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,5,1.05 [0.99-1.12],0.124267788599396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MUC13,Mucin-13,Inverse variance weighted,5,1.05 [0.99-1.11],0.129455010775876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,5,0.97 [0.94-1.01],0.132213827918727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANGPT2,Angiopoietin-2,Inverse variance weighted,5,1.03 [0.99-1.07],0.133150178732632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.97 [0.93-1.01],0.134492035455292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,0.97 [0.93-1.01],0.136735964346373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL25,C-C motif chemokine 25,Inverse variance weighted,5,1.04 [0.99-1.09],0.138134418343923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAYN,Layilin,Inverse variance weighted,5,0.97 [0.94-1.01],0.141118645806823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS4,Galectin-4,Inverse variance weighted,5,1.06 [0.98-1.15],0.141539699172504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,1.03 [0.99-1.08],0.142027406974861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.97 [0.93-1.01],0.144838001297503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRELP,Prolargin,Inverse variance weighted,5,0.97 [0.94-1.01],0.145153187765525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,5,0.98 [0.94-1.01],0.146371306390112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FSTL1,Follistatin-related protein 1,Inverse variance weighted,5,0.97 [0.93-1.01],0.147329949695894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGF5,Fibroblast growth factor 5,Inverse variance weighted,5,0.98 [0.94-1.01],0.147344231156829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,5,0.96 [0.92-1.01],0.1491704555165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE6,Ribonuclease K6,Inverse variance weighted,5,0.97 [0.94-1.01],0.149730987813399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD48,CD48 antigen,Inverse variance weighted,5,0.97 [0.94-1.01],0.149840737999603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,5,1.03 [0.99-1.07],0.150091026303962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD59,CD59 glycoprotein,Inverse variance weighted,5,0.97 [0.94-1.01],0.150868287076982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS8,Prostasin,Inverse variance weighted,5,1.04 [0.99-1.1],0.15114083210746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,0.97 [0.94-1.01],0.152044276835054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CX3CL1,Fractalkine,Inverse variance weighted,5,0.96 [0.92-1.01],0.154407494974184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,5,0.97 [0.94-1.01],0.15471256856271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,5,0.97 [0.94-1.01],0.155342160965747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,5,0.97 [0.94-1.01],0.156773612878563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DTNB,Dystrobrevin beta,Inverse variance weighted,5,0.97 [0.93-1.01],0.157001124405527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,5,0.97 [0.94-1.01],0.158257342448455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,5,0.97 [0.93-1.01],0.161366060715421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,5,1.03 [0.99-1.06],0.161562088662812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,5,1.03 [0.99-1.06],0.163231675346481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,0.97 [0.94-1.01],0.163858795188493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC1,Sialoadhesin,Inverse variance weighted,5,1.03 [0.99-1.06],0.163966351750308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,5,0.98 [0.95-1.01],0.164703988306012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,5,0.96 [0.9-1.02],0.166028473134841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,5,0.97 [0.92-1.01],0.167373396581273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.96 [0.92-1.02],0.167866392139241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD46,Membrane cofactor protein,Inverse variance weighted,5,0.97 [0.94-1.01],0.169815801466623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,5,0.97 [0.94-1.01],0.171620846466748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD7,T-cell antigen CD7,Inverse variance weighted,5,0.97 [0.94-1.01],0.177457410400943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGF23,Fibroblast growth factor 23,Inverse variance weighted,5,1.04 [0.98-1.09],0.180987229500417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,5,0.96 [0.91-1.02],0.181542360339013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,5,0.98 [0.94-1.01],0.181786817035157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,5,1.03 [0.99-1.06],0.181861493533961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPPC,C-type natriuretic peptide,Inverse variance weighted,5,1.03 [0.98-1.08],0.185936115607698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,5,1.03 [0.98-1.09],0.187175892056907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP7,Matrilysin,Inverse variance weighted,5,1.03 [0.98-1.08],0.190480479738644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL20,C-C motif chemokine 20,Inverse variance weighted,5,1.05 [0.98-1.12],0.190996311845496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,5,0.98 [0.94-1.01],0.194590337074758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,5,1.03 [0.99-1.07],0.197484053172136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH1,Cadherin-1,Inverse variance weighted,5,1.02 [0.99-1.06],0.197662202034123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,5,0.98 [0.94-1.01],0.200676149926586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PCDH1,Protocadherin-1,Inverse variance weighted,5,1.03 [0.99-1.07],0.203388925635509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,5,0.98 [0.95-1.01],0.20516468636631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,5,0.98 [0.95-1.01],0.205477168315664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RTN4R,Reticulon-4 receptor,Inverse variance weighted,5,1.05 [0.97-1.13],0.208185275486424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,Inverse variance weighted,5,1.02 [0.99-1.06],0.209814551672703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,5,0.97 [0.93-1.02],0.210445971574035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,5,0.98 [0.94-1.01],0.212198679832515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,5,1.04 [0.98-1.1],0.213590003102741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ENAH,Protein enabled homolog,Inverse variance weighted,5,0.98 [0.94-1.01],0.214394138037308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,5,1.02 [0.99-1.07],0.219502632697946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,5,1.03 [0.98-1.09],0.220297237803375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,5,0.98 [0.94-1.02],0.221133877199094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDCD1,Programmed cell death protein 1,Inverse variance weighted,5,0.98 [0.94-1.01],0.223791943463374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GRN,Progranulin,Inverse variance weighted,5,0.98 [0.94-1.01],0.228725503141809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,5,0.98 [0.94-1.02],0.229524641663955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PCDH7,Protocadherin-7,Inverse variance weighted,5,1.03 [0.98-1.07],0.230005294173063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,5,0.97 [0.93-1.02],0.230885327894646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,5,0.98 [0.94-1.02],0.231079166010915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,1.02 [0.98-1.06],0.236104342445832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DPY30,Protein dpy-30 homolog,Inverse variance weighted,5,0.97 [0.93-1.02],0.23776992143178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,5,0.98 [0.95-1.01],0.238418385527082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NECTIN4,Nectin-4,Inverse variance weighted,5,0.98 [0.94-1.02],0.24500003511949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD27,CD27 antigen,Inverse variance weighted,5,0.98 [0.94-1.02],0.246404912453049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL15,C-C motif chemokine 15,Inverse variance weighted,5,1.02 [0.99-1.05],0.246426119414286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PREB,Prolactin regulatory element-binding protein,Inverse variance weighted,5,1.03 [0.98-1.07],0.248140307389165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,0.98 [0.94-1.02],0.248987737358824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL19,Interleukin-19,Inverse variance weighted,5,0.98 [0.94-1.02],0.251842529520837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DSG3,Desmoglein-3,Inverse variance weighted,5,0.98 [0.94-1.02],0.255392927759447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,5,0.96 [0.9-1.03],0.255887523880882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,5,0.98 [0.94-1.02],0.256951057293889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,5,0.98 [0.94-1.02],0.258402275511252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.98 [0.94-1.02],0.261691223560192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD93,Complement component C1q receptor,Inverse variance weighted,5,0.98 [0.94-1.02],0.26206914739027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK11,Kallikrein-11,Inverse variance weighted,5,0.98 [0.94-1.02],0.263705993085761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,5,1.03 [0.98-1.07],0.26695425717226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,5,1.02 [0.98-1.06],0.268187463860751,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADM,Pro-adrenomedullin,Inverse variance weighted,5,0.97 [0.92-1.02],0.279143543942656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,5,1.02 [0.98-1.06],0.279242435273159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,5,0.98 [0.94-1.02],0.280640606073423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALCA,Calcitonin,Inverse variance weighted,5,0.96 [0.9-1.03],0.282600160478642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG1A,Lithostathine-1-alpha,Inverse variance weighted,5,1.02 [0.98-1.06],0.283455820871864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPRR3,Small proline-rich protein 3,Inverse variance weighted,5,0.98 [0.95-1.02],0.286126555365202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH3,Cadherin-3,Inverse variance weighted,5,0.98 [0.94-1.02],0.2888495110787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VASN,Vasorin,Inverse variance weighted,5,0.97 [0.92-1.03],0.291288382244809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,5,0.98 [0.94-1.02],0.292964764986513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,5,1.02 [0.98-1.06],0.29462883235946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,5,1.02 [0.98-1.07],0.295104417017343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,5,0.97 [0.91-1.03],0.299287875475062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,5,0.98 [0.94-1.02],0.301136677163577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,5,0.96 [0.9-1.03],0.304821278577849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,5,0.98 [0.95-1.02],0.308646509691291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WNT9A,Protein Wnt-9a,Inverse variance weighted,5,0.98 [0.95-1.02],0.31119704367917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,5,1.02 [0.98-1.05],0.312388651515507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL11,Eotaxin,Inverse variance weighted,5,1.04 [0.96-1.14],0.32060979707809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH6,Cadherin-6,Inverse variance weighted,5,0.98 [0.93-1.02],0.322764298740205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,5,0.98 [0.94-1.02],0.323897025886764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,5,1.02 [0.98-1.05],0.326246556605554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,5,0.98 [0.94-1.02],0.328898536514837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DRAXIN,Draxin,Inverse variance weighted,5,0.98 [0.95-1.02],0.329303753418896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCGN,Secretagogin,Inverse variance weighted,5,1.03 [0.97-1.1],0.333377111073261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GUCA2A,Guanylin,Inverse variance weighted,5,0.97 [0.92-1.03],0.335886182679516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.02 [0.98-1.08],0.338998860304461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DLL1,Delta-like protein 1,Inverse variance weighted,5,0.98 [0.95-1.02],0.343698187906869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPPB,Natriuretic peptides B,Inverse variance weighted,5,0.98 [0.94-1.02],0.347081682270891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,OCLN,Occludin,Inverse variance weighted,5,1.03 [0.96-1.11],0.347925627509279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MELTF,Melanotransferrin,Inverse variance weighted,5,1.02 [0.98-1.07],0.348604780383928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,5,1.02 [0.98-1.07],0.348757108133073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,5,1.02 [0.98-1.06],0.34958457919033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,5,1.02 [0.97-1.08],0.354298978474103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD276,CD276 antigen,Inverse variance weighted,5,0.99 [0.95-1.02],0.357612848574328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PI3,Elafin,Inverse variance weighted,5,0.98 [0.94-1.02],0.360122372127535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,5,0.98 [0.94-1.02],0.361758993059329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,5,0.98 [0.94-1.02],0.364286339557064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,5,0.98 [0.95-1.02],0.366234787926582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEPTIN8,Septin-8,Inverse variance weighted,5,0.98 [0.92-1.03],0.368656243980804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN4,CCN family member 4,Inverse variance weighted,5,0.98 [0.95-1.02],0.3687501119613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK8,Kallikrein-8,Inverse variance weighted,5,0.98 [0.93-1.03],0.369023642619799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN5,CCN family member 5,Inverse variance weighted,5,0.98 [0.94-1.02],0.371262904167187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,5,0.98 [0.95-1.02],0.372109637611415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.98 [0.95-1.02],0.375436541352035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RGMB,RGM domain family member B,Inverse variance weighted,5,0.98 [0.95-1.02],0.378974036978863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.03 [0.97-1.1],0.379206617788561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPARCL1,SPARC-like protein 1,Inverse variance weighted,5,0.98 [0.95-1.02],0.380346713543215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,5,1.02 [0.97-1.08],0.380453551380133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,5,1.02 [0.98-1.06],0.383079995872194,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFNA1,Ephrin-A1,Inverse variance weighted,5,0.98 [0.94-1.02],0.383787574825273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,5,0.98 [0.95-1.02],0.38998422866906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALB1,Calbindin,Inverse variance weighted,5,0.97 [0.91-1.04],0.391406529215787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,5,0.97 [0.91-1.04],0.394892131569943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,5,0.98 [0.94-1.02],0.397553580951198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KITLG,Kit ligand,Inverse variance weighted,5,0.98 [0.95-1.02],0.398065082205057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BSG,Basigin,Inverse variance weighted,5,0.98 [0.95-1.02],0.400318425499112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,5,0.97 [0.9-1.04],0.40228071698051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP3,Stromelysin-1,Inverse variance weighted,5,1.01 [0.98-1.04],0.402370295945918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,5,1.02 [0.98-1.06],0.403066290785345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,5,0.97 [0.92-1.04],0.406316779891585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGRN,Agrin,Inverse variance weighted,5,1.03 [0.96-1.12],0.406443669736463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PENK,Proenkephalin-A,Inverse variance weighted,5,0.98 [0.93-1.03],0.413594772391334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EGFLAM,Pikachurin,Inverse variance weighted,5,1.03 [0.97-1.09],0.413873787323227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,5,1.02 [0.98-1.05],0.414706850956311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC10A,C-type lectin domain family 10 member A,Inverse variance weighted,5,0.99 [0.95-1.02],0.422539802104255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,5,1.02 [0.98-1.06],0.422648456012291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,5,0.99 [0.95-1.02],0.426641654828509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3B,Protein FAM3B,Inverse variance weighted,5,1.02 [0.97-1.08],0.427717488983321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD83,CD83 antigen,Inverse variance weighted,5,1.02 [0.98-1.06],0.429602341535583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,5,0.99 [0.95-1.02],0.430548697495496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,5,0.99 [0.95-1.02],0.430781563984472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHGA,Chromogranin-A,Inverse variance weighted,5,0.98 [0.95-1.02],0.433364317930814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,5,1.02 [0.97-1.06],0.435430074100757,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,5,0.98 [0.93-1.03],0.444898453415359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL17C,Interleukin-17C,Inverse variance weighted,5,1.02 [0.98-1.06],0.446727716909572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,5,1.03 [0.96-1.09],0.447763115740684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,5,1.02 [0.97-1.08],0.448093663306462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK10,Kallikrein-10,Inverse variance weighted,5,1.02 [0.97-1.07],0.448392013480541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.99 [0.95-1.02],0.45293300510246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.99 [0.95-1.02],0.45475813120719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,5,0.98 [0.94-1.03],0.456718288400654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.99 [0.96-1.02],0.457479239607428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,5,0.99 [0.95-1.02],0.458175864062162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA4,Carbonic anhydrase 4,Inverse variance weighted,5,0.99 [0.95-1.02],0.459990023574559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD164,Sialomucin core protein 24,Inverse variance weighted,5,0.99 [0.95-1.03],0.468304862335517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA9,Carbonic anhydrase 9,Inverse variance weighted,5,1.01 [0.98-1.05],0.468914702354186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,5,0.98 [0.93-1.03],0.46894032745537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,5,1.03 [0.95-1.12],0.471813137602739,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,5,1.01 [0.98-1.05],0.475527547671424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,5,1.02 [0.97-1.07],0.477420853765916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AREG,Amphiregulin,Inverse variance weighted,5,1.02 [0.97-1.07],0.477559294555485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Inverse variance weighted,5,1.02 [0.96-1.09],0.478696647178935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG1B,Lithostathine-1-beta,Inverse variance weighted,5,1.02 [0.97-1.07],0.480892463407775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,5,1.01 [0.98-1.05],0.481574770185768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,5,0.99 [0.95-1.02],0.486679255823378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MATN2,Matrilin-2,Inverse variance weighted,5,1.01 [0.98-1.05],0.487142799611214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASE4,Ribonuclease 4,Inverse variance weighted,5,0.98 [0.92-1.04],0.490004689207861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,5,0.98 [0.94-1.03],0.490620205221711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BOC,Brother of CDO,Inverse variance weighted,5,1.01 [0.97-1.05],0.494014245177425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,5,1.01 [0.98-1.05],0.494333639336323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,5,0.98 [0.94-1.03],0.495248409685646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,5,1.01 [0.98-1.05],0.495393268468301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD160,CD160 antigen,Inverse variance weighted,5,0.99 [0.95-1.02],0.498100493855841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NXPH3,Neurexophilin-3,Inverse variance weighted,5,1.01 [0.98-1.05],0.499699162914425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GPC1,Glypican-1,Inverse variance weighted,5,1.02 [0.97-1.08],0.500543876725921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,5,1.01 [0.97-1.05],0.500963443376834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CST6,Cystatin-M,Inverse variance weighted,5,0.99 [0.95-1.02],0.502517350973906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,5,0.99 [0.95-1.03],0.504184925266311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MB,Myoglobin,Inverse variance weighted,5,0.98 [0.93-1.04],0.504318998969928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.01 [0.98-1.05],0.50552205729601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,5,1.01 [0.97-1.05],0.506204641702661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RGMA,Repulsive guidance molecule A,Inverse variance weighted,5,1.01 [0.98-1.05],0.507495455653864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,5,1.01 [0.97-1.05],0.512940424253791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,5,0.99 [0.95-1.03],0.513143840836653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.02 [0.95-1.1],0.519942568602663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,5,1.01 [0.98-1.05],0.522616774779588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ULBP2,UL16-binding protein 2,Inverse variance weighted,5,0.99 [0.94-1.03],0.526281338174599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,5,1.02 [0.96-1.09],0.52757892444256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,5,0.98 [0.93-1.04],0.533684225907795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.99 [0.95-1.03],0.533761826621047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,5,0.99 [0.95-1.03],0.536523450307464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,5,0.99 [0.95-1.03],0.538193272958611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,5,1.01 [0.97-1.05],0.543897934525974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,5,0.99 [0.95-1.03],0.555874731291652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADA2,Adenosine deaminase 2,Inverse variance weighted,5,1.01 [0.97-1.06],0.557909840700495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,0.99 [0.94-1.04],0.558885807689139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,1.01 [0.97-1.05],0.559444462294927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,5,0.99 [0.95-1.03],0.559764583778951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,5,1.01 [0.97-1.05],0.560380241607165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,5,0.99 [0.95-1.03],0.566334762728814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,UMOD,Uromodulin,Inverse variance weighted,5,0.99 [0.94-1.03],0.567562973079615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,5,0.99 [0.94-1.04],0.568185488612673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.99 [0.94-1.04],0.568775635408852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,5,0.99 [0.96-1.03],0.572677982151668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP6,Gastrotropin,Inverse variance weighted,5,0.99 [0.94-1.03],0.576373998296597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,5,0.99 [0.94-1.04],0.577580230112654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RSPO3,R-spondin-3,Inverse variance weighted,5,0.99 [0.95-1.03],0.578195320616281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CST3,Cystatin-C,Inverse variance weighted,5,0.99 [0.95-1.03],0.57848332787071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DKK3,Dickkopf-related protein 3,Inverse variance weighted,5,1.01 [0.97-1.06],0.580069255696881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS9,Galectin-9,Inverse variance weighted,5,1.01 [0.97-1.06],0.580618233609754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL16,Pro-interleukin-16,Inverse variance weighted,5,1.01 [0.97-1.06],0.584901471417169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCN3,CCN family member 3,Inverse variance weighted,5,0.99 [0.94-1.03],0.58624162432815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,5,1.01 [0.96-1.07],0.586628089458667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SNCG,Gamma-synuclein,Inverse variance weighted,5,1.01 [0.97-1.05],0.597624067823606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.99 [0.94-1.04],0.603108741979977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,5,1.01 [0.97-1.06],0.611801735596482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SDC1,Syndecan-1,Inverse variance weighted,5,1.01 [0.97-1.06],0.612589591778324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS2,Trypsin-2,Inverse variance weighted,5,0.99 [0.95-1.03],0.612641059176603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DLK1,Protein delta homolog 1,Inverse variance weighted,5,1.02 [0.95-1.1],0.612895553461081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PSAP,Prosaposin,Inverse variance weighted,5,1.01 [0.97-1.06],0.61380303857972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,5,0.99 [0.95-1.03],0.615179782375076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,5,1.01 [0.97-1.05],0.619088100717646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NECTIN2,Nectin-2,Inverse variance weighted,5,0.99 [0.95-1.03],0.625778949344489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TCN2,Transcobalamin-2,Inverse variance weighted,5,1.01 [0.97-1.06],0.62963677105863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,5,0.99 [0.93-1.05],0.63008567837722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHGB,Secretogranin-1,Inverse variance weighted,5,0.99 [0.96-1.03],0.631837249680138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,5,0.99 [0.96-1.03],0.633214516220481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,5,0.99 [0.97-1.02],0.634361114087895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.01 [0.97-1.05],0.634896227699327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,5,1.01 [0.98-1.03],0.636127665955648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,5,1.01 [0.97-1.05],0.639916529826025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,5,1.01 [0.96-1.06],0.642176361421772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VGF,Neurosecretory protein VGF,Inverse variance weighted,5,1.02 [0.95-1.09],0.644068011811558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDH17,Cadherin-17,Inverse variance weighted,5,1.01 [0.95-1.08],0.648611209827795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,5,0.99 [0.95-1.04],0.650053507923083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EDN1,Endothelin-1,Inverse variance weighted,5,0.99 [0.95-1.03],0.65125502759279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ANG,Angiogenin,Inverse variance weighted,5,1.01 [0.95-1.08],0.663074217165258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,5,1.01 [0.95-1.08],0.663302955891777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,5,1.01 [0.97-1.05],0.664058060699405,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LMNB2,Lamin-B2,Inverse variance weighted,5,0.99 [0.95-1.04],0.667361849725547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,5,1.02 [0.94-1.11],0.66759078231678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,Inverse variance weighted,5,1.01 [0.96-1.07],0.670445659936114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,5,1.01 [0.97-1.06],0.670894266314388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,5,1.01 [0.97-1.05],0.67334185678308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,1.01 [0.96-1.07],0.673686519479676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PGF,Placenta growth factor,Inverse variance weighted,5,1.01 [0.97-1.05],0.680311524480863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,5,1.01 [0.97-1.05],0.685755939234662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MMP10,Stromelysin-2,Inverse variance weighted,5,1.01 [0.97-1.05],0.68832585548975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEZ6L,Seizure 6-like protein,Inverse variance weighted,5,1.01 [0.95-1.08],0.692964672077951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DCN,Decorin,Inverse variance weighted,5,0.99 [0.94-1.04],0.69390067364291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSTB,Cystatin-B,Inverse variance weighted,5,1.01 [0.97-1.04],0.701816780454026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,5,0.99 [0.94-1.05],0.702584431204472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,5,1.01 [0.96-1.07],0.710757189906343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,5,0.99 [0.96-1.03],0.711177642846257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,5,0.99 [0.96-1.03],0.711546539473511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF1,Trefoil factor 1,Inverse variance weighted,5,1.01 [0.95-1.08],0.718518703826003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,5,1.01 [0.95-1.08],0.720075091987814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,5,1.01 [0.96-1.06],0.721636697150816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,5,1.01 [0.97-1.05],0.721814376164144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ELN,Elastin,Inverse variance weighted,5,0.99 [0.96-1.03],0.723513609817094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,5,0.99 [0.94-1.05],0.724383999338067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,5,0.99 [0.96-1.03],0.727284403203057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,5,0.99 [0.96-1.03],0.727720786366906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,5,0.99 [0.96-1.03],0.734369020243663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SCGB1A1,Uteroglobin,Inverse variance weighted,5,0.99 [0.95-1.04],0.734775768225326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CA14,Carbonic anhydrase 14,Inverse variance weighted,5,0.99 [0.96-1.03],0.73516442411204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS3,Galectin-3,Inverse variance weighted,5,1.01 [0.94-1.09],0.736787522997788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.99 [0.93-1.05],0.739890578320531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RTBDN,Retbindin,Inverse variance weighted,5,1.01 [0.95-1.08],0.741766153250446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,5,0.99 [0.96-1.03],0.74181967199978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,5,1.01 [0.96-1.07],0.742847222786516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.01 [0.97-1.05],0.744441715159014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,5,1.01 [0.96-1.06],0.744898455474874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,5,0.99 [0.96-1.03],0.745312989940922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AMBP,Protein AMBP,Inverse variance weighted,5,1.01 [0.97-1.04],0.746157307967384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HNMT,Histamine N-methyltransferase,Inverse variance weighted,5,1.01 [0.97-1.05],0.747914424292823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ALCAM,CD166 antigen,Inverse variance weighted,5,0.99 [0.96-1.03],0.748674690964353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,5,1.01 [0.97-1.05],0.752019250481005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3C,Protein FAM3C,Inverse variance weighted,5,0.99 [0.92-1.06],0.75778350993819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,5,1.01 [0.94-1.09],0.757794726266043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,5,0.99 [0.94-1.05],0.766497078385375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,5,0.99 [0.96-1.03],0.767330581417157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,5,0.99 [0.94-1.05],0.768091897858885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.01 [0.96-1.06],0.769166492700411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,5,0.99 [0.94-1.04],0.76925141407202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,5,0.99 [0.96-1.03],0.77191373335428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDSN,Corneodesmosin,Inverse variance weighted,5,1.01 [0.96-1.06],0.77281029889344,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,5,0.99 [0.96-1.03],0.773187306597408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,0.99 [0.96-1.03],0.774658267528094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,5,1.01 [0.97-1.04],0.774934481644615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,5,1.01 [0.97-1.05],0.777605070332919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,5,1.01 [0.97-1.04],0.785001575196588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ABCA2,ATP-binding cassette sub-family A member 2,Inverse variance weighted,5,1.01 [0.96-1.05],0.786671504550873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FCRL2,Fc receptor-like protein 2,Inverse variance weighted,5,0.99 [0.96-1.04],0.791751521204437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,5,1.01 [0.95-1.07],0.793756425006221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,5,1 [0.96-1.03],0.795482614237937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PRSS27,Serine protease 27,Inverse variance weighted,5,0.99 [0.95-1.04],0.796937786937187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALB2,Calretinin,Inverse variance weighted,5,0.99 [0.93-1.06],0.79984386123642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTSL,Cathepsin L1,Inverse variance weighted,5,1 [0.97-1.04],0.802740131695486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1 [0.96-1.03],0.803465453427932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,5,1 [0.96-1.03],0.804918555459562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,5,1 [0.96-1.04],0.808398543151145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,B2M,Beta-2-microglobulin,Inverse variance weighted,5,1 [0.96-1.03],0.809030055845731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,5,0.99 [0.95-1.04],0.811951773682505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,5,1 [0.98-1.03],0.812731349175991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,5,0.99 [0.95-1.04],0.816762401976551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TGFA,Protransforming growth factor alpha,Inverse variance weighted,5,1.01 [0.95-1.07],0.817150734455382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,5,1 [0.97-1.04],0.820636146248501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,INHBB,Inhibin beta B chain,Inverse variance weighted,5,0.99 [0.95-1.04],0.825589696380412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,5,1.01 [0.96-1.06],0.825762817447169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,5,1 [0.96-1.05],0.825987405495919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MSMB,Beta-microseminoprotein,Inverse variance weighted,5,1 [0.97-1.04],0.830070353990682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,5,1 [0.97-1.04],0.837333831232217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,5,0.99 [0.93-1.06],0.843572749278327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,5,1 [0.97-1.04],0.849335327584437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,5,1 [0.96-1.04],0.865962423504755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CCL23,C-C motif chemokine 23,Inverse variance weighted,5,1 [0.96-1.03],0.86628139338575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNASET2,Ribonuclease T2,Inverse variance weighted,5,1 [0.97-1.04],0.868214134382755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,1 [0.96-1.04],0.870728328103514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CAPG,Macrophage-capping protein,Inverse variance weighted,5,1 [0.97-1.03],0.874168723782278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,1 [0.95-1.06],0.876842321181445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,1 [0.94-1.05],0.879442147845283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,THBD,Thrombomodulin,Inverse variance weighted,5,1 [0.96-1.04],0.880723024043147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RETN,Resistin,Inverse variance weighted,5,1 [0.96-1.04],0.885473119455633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,5,1 [0.96-1.04],0.889605757609631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,JAM2,Junctional adhesion molecule B,Inverse variance weighted,5,1 [0.96-1.04],0.892400790678401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1 [0.96-1.04],0.892438349931314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1 [0.95-1.06],0.892975612508896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MDK,Midkine,Inverse variance weighted,5,1 [0.96-1.05],0.893827752918724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,AGER,Advanced glycosylation end product-specific receptor,Inverse variance weighted,5,1 [0.95-1.05],0.895094169808249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SEMA3F,Semaphorin-3F,Inverse variance weighted,5,1 [0.96-1.05],0.896180342917281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPON1,Spondin-1,Inverse variance weighted,5,1 [0.95-1.06],0.901250939281001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,5,1 [0.97-1.04],0.901269860252768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1 [0.96-1.04],0.903653320699109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1 [0.94-1.06],0.90485520049606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,5,1 [0.96-1.03],0.906604554201168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,FAM3D,Protein FAM3D,Inverse variance weighted,5,1 [0.97-1.03],0.906715233993568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,LGALS1,Galectin-1,Inverse variance weighted,5,1 [0.95-1.05],0.907060866969056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,5,1 [0.94-1.06],0.91180423982717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,5,1 [0.96-1.04],0.912777024207919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,5,1 [0.95-1.05],0.916439646504582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,5,1 [0.96-1.04],0.91784414343438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,MOG,Myelin-oligodendrocyte glycoprotein,Inverse variance weighted,5,1 [0.93-1.07],0.919986100178953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1 [0.93-1.08],0.924280530418456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CD302,CD302 antigen,Inverse variance weighted,5,1 [0.95-1.05],0.929675203908806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SPON2,Spondin-2,Inverse variance weighted,5,1 [0.96-1.04],0.936266689301254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,5,1 [0.96-1.04],0.93992765940911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1 [0.94-1.07],0.940286926833136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,XCL1,Lymphotactin,Inverse variance weighted,5,1 [0.95-1.06],0.942132257492773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,5,1 [0.96-1.04],0.946871407792552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PALM2,Paralemmin-2,Inverse variance weighted,5,1 [0.96-1.04],0.954476017480679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,DKK4,Dickkopf-related protein 4,Inverse variance weighted,5,1 [0.95-1.06],0.954746126260501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1 [0.96-1.04],0.957040249035965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,KLK6,Kallikrein-6,Inverse variance weighted,5,1 [0.94-1.06],0.957531316216594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1 [0.96-1.04],0.960073017348227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,F3,Tissue factor,Inverse variance weighted,5,1 [0.95-1.05],0.960135603059966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,NUCB2,Nucleobindin-2,Inverse variance weighted,5,1 [0.96-1.04],0.960680063985307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1 [0.96-1.04],0.964148190176983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,5,1 [0.96-1.04],0.966009924223113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,TFF2,Trefoil factor 2,Inverse variance weighted,5,1 [0.94-1.06],0.968671604098613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,5,1 [0.96-1.04],0.972736586137045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,XG,Glycoprotein Xg,Inverse variance weighted,5,1 [0.97-1.03],0.985149468752266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,5,1 [0.96-1.04],0.987127633620904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,5,1 [0.96-1.04],0.992021893962968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,5,1 [0.96-1.04],0.992930887957115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,5,1 [0.95-1.05],0.994148779808653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,5,1 [0.97-1.03],0.996363670107479,trans
